NCM
GILD icon

Nearwater Capital Markets’s Gilead Sciences GILD Stock Holding History

Nearwater Capital Markets’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-200,000
Closed -$27.9M – 114
2026
Q1 		$27.9M Sell
200,000
-813,000
-80% -$114M 0.66% 50
2025
Q4 		$124M Buy
1,013,000
+423,000
+72% +$51.4M 2.13% 14
2025
Q3 		$65.5M Buy
590,000
+440,000
+293% +$50M 0.88% 26
2025
Q2 		$16.6M Buy
+150,000
New +$16M 0.27% 62

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nearwater Capital Markets's GILD Position: Q2 2026 in Review

Nearwater Capital Markets sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 200,000 shares — an estimated $27.9M sold.

Nearwater Capital Markets first reported a position in GILD in Q2 2025 and held it in 4 quarters. The position peaked at $124M in Q4 2025. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Nearwater Capital Markets reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Nearwater Capital Markets sold 200,000 Gilead Sciences shares in Q2 2026, an estimated $27.9M.
  • Nearwater Capital Markets first reported a position in Gilead Sciences in Q2 2025 and held it in 4 quarters.
  • Nearwater Capital Markets's Gilead Sciences position peaked at $124M in Q4 2025.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Nearwater Capital Markets's 13F filing for Q2 2026, filed 14 Aug 2026.